- Home
- ACHV vs MMLP Comparison
ACHV vs MMLP Comparison
Compare ACHV & MMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- MMLP
- Stock Information
- Founded
- ACHV N/A
- MMLP 2002
- Country
- ACHV United States
- MMLP United States
- Employees
- ACHV N/A
- MMLP N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MMLP Oil Refining/Marketing
- Sector
- ACHV Health Care
- MMLP Energy
- Exchange
- ACHV Nasdaq
- MMLP Nasdaq
- Market Cap
- ACHV 131.2M
- MMLP 111.3M
- IPO Year
- ACHV N/A
- MMLP 2002
- Fundamental
- Price
- ACHV $2.55
- MMLP $3.41
- Analyst Decision
- ACHV Strong Buy
- MMLP
- Analyst Count
- ACHV 3
- MMLP 0
- Target Price
- ACHV $14.33
- MMLP N/A
- AVG Volume (30 Days)
- ACHV 652.7K
- MMLP 15.6K
- Earning Date
- ACHV 08-07-2025
- MMLP 07-16-2025
- Dividend Yield
- ACHV N/A
- MMLP 0.59%
- EPS Growth
- ACHV N/A
- MMLP N/A
- EPS
- ACHV N/A
- MMLP N/A
- Revenue
- ACHV N/A
- MMLP $715,480,000.00
- Revenue This Year
- ACHV N/A
- MMLP $4.19
- Revenue Next Year
- ACHV N/A
- MMLP N/A
- P/E Ratio
- ACHV N/A
- MMLP N/A
- Revenue Growth
- ACHV N/A
- MMLP N/A
- 52 Week Low
- ACHV $1.84
- MMLP $2.56
- 52 Week High
- ACHV $5.31
- MMLP $4.02
- Technical
- Relative Strength Index (RSI)
- ACHV 46.32
- MMLP 70.92
- Support Level
- ACHV $2.37
- MMLP $3.24
- Resistance Level
- ACHV $2.56
- MMLP $3.50
- Average True Range (ATR)
- ACHV 0.12
- MMLP 0.20
- MACD
- ACHV 0.01
- MMLP 0.06
- Stochastic Oscillator
- ACHV 47.37
- MMLP 87.84
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.